High-risk women need more frequent doses of HIV drugs Researchers say more frequent pre-exposure prophylaxis is required to protect women from HIV.…
Exposure to atazanavir in womb linked to neurodevelopmental problems in infants Babies exposed to the HIV drug atazanavir in the womb may have impaired language and social-emotional development at one year, suggests a new study.…
HIV resistance to tenofovir surprisingly common International study finds high proportion of HIV patients were resistant to cART drug tenofovir.…
Researchers unravel function of HIV defence protein Researchers investigate why TRIM5α protein lost ability to degrade HIV in rhesus monkey study.…
Targeting hepatitis C — how new treatments work There are >185 million people with hepatitis C infection worldwide but new treatments mean that most people with access to therapy can now be cured. …
Pre-exposure prophylaxis necessary to reduce HIV infection rate among MSM Offering men who have sex with men antiretroviral therapy as pre-exposure prophylaxis is necessary if the UK is to achieve a marked reduction in the annual rate of HIV infections by the end of this decade, according to new research.…
On-demand prophylaxis protects against HIV infection in at-risk men Randomised trial shows pre-exposure prophylaxis reduced the risk of HIV transmission by 86%.…
Alcoholism drug could help eliminate dormant HIV Disulfiram treatment can reactivate latent HIV, which could help eliminate the cells harbouring the virus, report finds.…
People taking HIV drugs rises to almost 16 million, UNAIDs reports The number of people receiving HIV treatment reached 15.8 million in June 2015, an increase of 2.2 million on the previous year, says a new report by UNAIDS.…
Tamiflu and Relenza need a better evidence base for influenza, report finds The evidence base for influenza drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza) must be strengthened, says a report from the Wellcome Trust and the Academy of Medical Sciences.…
